Concourse Financial Group Securities, Inc. Horizon Therapeutics Public LTD CO Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$98.98 - $115.74 $8,611 - $10,069	-87 Reduced 10.06%	778 $90,000
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $1,734 - $2,022	-18 Reduced 2.04%	865 $88,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $72,977 - $77,180	-680 Reduced 43.51%	883 $96,000
Q4 2022 Jan 30, 2023	BUY	$62.39 - $113.8 $97,515 - $177,869	1,563 New	1,563 $0
Q3 2022 Nov 15, 2022	SELL	$58.92 - $84.67 $126,854 - $182,294	-2,153 Closed	0 $0
Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $21,120 - $30,951	266 Added 14.1%	2,153 $172,000
Q1 2022 May 09, 2022	SELL	$86.42 - $109.81 $29,123 - $37,005	-337 Reduced 15.15%	1,887 $199,000
Q4 2021 Feb 07, 2022	BUY	$98.56 - $119.91 $13,009 - $15,828	132 Added 6.31%	2,224 $240,000
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $4,779 - $5,739	52 Added 2.55%	2,092 $229,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $32,771 - $36,449	-380 Reduced 15.7%	2,040 $191,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $6,536 - $8,688	91 Added 3.91%	2,420 $223,000
Q4 2020 Feb 02, 2021	BUY	$67.0 - $84.39 $51,992 - $65,486	776 Added 49.97%	2,329 $170,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $66,552 - $96,315	1,205 Added 346.26%	1,553 $121,000
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $362 - $683	12 Added 3.57%	348 $19,000
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $2,810 - $4,357	113 Added 50.67%	336 $10,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $2,873 - $4,143	113 Added 102.73%	223 $8,000
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $2,875 - $3,496	-125 Reduced 53.19%	110 $3,000
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $5,360 - $6,692	235 New	235 $6,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account